Strategic Communications and Marketing News Bureau

New sensors streamline detection of estrogenic compounds

CHAMPAIGN, lll. – Researchers have engineered new sensors that fluoresce in the presence of compounds that interact with estrogen receptors in human cells. The sensors detect natural or human-made substances that alter estrogenic signaling in the body.

The study appears in the journal Biotechnology and Bioengineering.

Estrogen occurs naturally in the body (in the form of 17-beta-estradiol), and a variety of plants (such as soybeans), pharmaceuticals, microbial byproducts and industrial chemicals (such as bisphenol A, in plastics) are also known to activate or block the activation of estrogen receptors in human cells.

“There are so many estrogenic compounds in our environment, and some of them could be a danger to health,” said University of Illinois chemical and biomolecular engineering professor Huimin Zhao, who led the research. Zhao also is an affiliate of the chemistry and biochemistry departments, the Center for Biophysics and Computational Biology, and the Institute for Genomic Biology, all at Illinois. “We are concerned about estrogenic compounds because they interact with the estrogen receptor, which plays an important role in many important biological processes, like reproduction, bone growth, cell differentiation and metabolism.”

The estrogen receptor is also implicated in a majority of breast cancers, he said, with compounds that activate it potentially spurring the growth of cancer cells.

The researchers used part of the estrogen receptor itself in the design of their new sensors. They took the region of the receptor that binds to estrogenic compounds (called the “ligand-binding domain”) and added two halves of a fluorescent protein that glows only when the halves are reunited. The ligand-binding domain changes its conformation when it binds to an estrogenic compound. This change, the researchers hoped, would draw the two parts of the fluorescent protein together to produce a signal.

In a series of trials, the researchers found that two of their sensors reliably signaled the presence of estrogenic compounds. The first, “sensor 2,” differentiated between compounds that activate and those that block estrogen receptors, glowing more brightly in the presence of one and dimming when bound to the other. A second bioengineered molecule, “sensor 6,” fluoresced in the presence of both types of compounds, making it a reliable indicator of chemicals that bind to the receptor.

When incubated in human cells, the sensors responded to estrogenic compounds within a few hours, Zhao said, with the fluorescent signals gradually increasing in strength up to 24 hours. “And also the sensitivity is pretty high,” he said. “Of course it depends on the compound that you’re testing; different compounds will have different affinities. But for a truly estrogenic compound, we can detect at the nanomolar level, a very low level.”

These are the first such sensors to work in human cells without costly additional chemical steps, he said.

The new sensors will help researchers and clinicians quickly and efficiently determine whether a food, drug or chemical substance interacts with estrogen receptors in human cells, Zhao said.

The National Science Foundation funded this research.

Editor’s note: To contact Huimin Zhao, call 217-333-2631; email zhao5@illinois.edu.
                       
The paper, “A New Fluorescence Complementation Biosensor for Detection of Estrogenic Compounds,” is available online or from the U. of I. News Bureau.

Read Next

Health and medicine Dr. Timothy Fan, left, sits in a consulting room with the pet owner. Between them stands the dog, who is looking off toward Fan.

How are veterinarians advancing cancer research in dogs, people?

CHAMPAIGN, Ill. — People are beginning to realize that dogs share a lot more with humans than just their homes and habits. Some spontaneously occurring cancers in dogs are genetically very similar to those in people and respond to treatment in similar ways. This means inventive new treatments in dogs, when effective, may also be […]

Honors From left, individuals awarded the 2025 Campus Awards for Excellence in Public Engagement are Antoinette Burton, director of the Humanities Research Institute; Ariana Mizan, undergraduate student in strategy, innovation and entrepreneurship; Lee Ragsdale, the reentry resource program director for the Education Justice Project; and Ananya Yammanuru, a graduate student in computer science. Photos provided.

Awards recognize excellence in public engagement

The 2025 Campus Awards for Excellence in Public Engagement were recently awarded to faculty, staff and community members who address critical societal issues.

Uncategorized Portrait of the researchers standing outside in front of a grove of trees.

Study links influenza A viral infection to microbiome, brain gene expression changes

CHAMPAIGN, Ill. — In a study of newborn piglets, infection with influenza A was associated with disruptions in the piglets’ nasal and gut microbiomes and with potentially detrimental changes in gene activity in the hippocampus, a brain structure that plays a central role in learning and memory. Maternal vaccination against the virus during pregnancy appeared […]

Strategic Communications and Marketing News Bureau

507 E. Green St
MC-426
Champaign, IL 61820

Email: stratcom@illinois.edu

Phone (217) 333-5010